default author photo

Hyma Vani Polimera

Pennsylvania State University - Penn State Hershey Medical Center

500 University Dr

Hershey, PA 17033

United States

SCHOLARLY PAPERS

2

DOWNLOADS

127

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

High Plasma IL-8 and PD-L1 are Associated With Reduced Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients (mCRPC)

Number of pages: 27 Posted: 18 Nov 2020
Pennsylvania State University - Penn State Hershey Medical Center, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Pennsylvania State University - Penn State Hershey Medical Center, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, ProteinSimple and Pennsylvania State University - Penn State Hershey Medical Center
Downloads 99 (699,467)

Abstract:

Loading...

plasma IL-8 & PD-L1, overall survival, metastatic prostate cancer

2.

Higher serum activin A predicts adverse outcomes in AI-refractory hormone receptor-positive metastatic breast cancer in the Phase III BOLERO-2 trial (everolimus + exemestane vs exemestane alone)

Number of pages: 18 Posted: 25 Mar 2026
affiliation not provided to SSRN, Thomas Jefferson University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Pennsylvania State University - Penn State Hershey Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Pennsylvania State University - Penn State Hershey Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN and Pennsylvania State University - Penn State Hershey Medical Center
Downloads 28 (1,385,945)

Abstract:

Loading...

Biomarkers, metastatic breast cancer, hormone receptor positive, serum activin A